Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Related Citations for PubMed (Select 23032828)

1.

Thrombophilic molecular markers in young patients (<40 years) with coronary artery disease.

Sherpa M, Sharma S, Avasthi R.

Indian J Pathol Microbiol. 2012 Jul-Sep;55(3):343-6. doi: 10.4103/0377-4929.101741.

2.

Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.

Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.

Blood Coagul Fibrinolysis. 2009 Jun;20(4):252-6. doi: 10.1097/MBC.0b013e3283255487.

PMID:
19349859
3.

Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.

Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR.

J Pediatr Gastroenterol Nutr. 2002 Nov;35(5):629-35.

PMID:
12454577
4.
5.

[Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].

Kovacheva K, Ivanov P, Konova E, Simeonova M, Komsa-Penkova R.

Akush Ginekol (Sofiia). 2007;46(7):10-6. Bulgarian.

PMID:
18333414
6.

Hereditary thrombophilic factors in stroke due to cerebral infarct.

Bolaman Z, Ozkul A, Kiylioglu N, Kadikoylu G, Erturk A, Batun S, Akyol A.

Am J Med Sci. 2009 Jan;337(1):11-3.

PMID:
19263510
7.

Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children.

Kenet G, Sadetzki S, Murad H, Martinowitz U, Rosenberg N, Gitel S, Rechavi G, Inbal A.

Stroke. 2000 Jun;31(6):1283-8.

8.

Impact of thrombophilic genetic factors on pulmonary embolism: early onset and recurrent incidences.

Ivanov P, Komsa-Penkova R, Kovacheva K, Ivanov Y, Stoyanova A, Ivanov I, Pavlov P, Glogovska P, Nojarov V.

Lung. 2008 Jan-Feb;186(1):27-36. Epub 2007 Dec 21.

PMID:
18097719
9.

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.

Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, Walker ID, Langhorne P, Brenkel I, Regan L, Greer I.

Health Technol Assess. 2006 Apr;10(11):1-110. Review.

10.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

PMID:
15886665
11.

Thrombophilia-related genetic variations in patients with pulmonary embolism in the main teaching hospital in Jordan.

Obeidat NM, Awidi A, Sulaiman NA, Abu-Khader IB.

Saudi Med J. 2009 Jul;30(7):921-5.

PMID:
19618008
12.

Cerebral venous and sinus thrombosis and thrombophilic mutations in Western Iran: association with factor V Leiden.

Rahimi Z, Mozafari H, Bigvand AH, Doulabi RM, Vaisi-Raygani A, Afshari D, Razazian N, Rezaei M.

Clin Appl Thromb Hemost. 2010 Aug;16(4):430-4. doi: 10.1177/1076029609335519. Epub 2009 Aug 23.

PMID:
19703820
13.

Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.

Rahimi Z, Ghaderi M, Nagel RL, Muniz A.

J Thromb Thrombolysis. 2008 Dec;26(3):229-33. Epub 2007 Nov 4.

PMID:
17982733
14.

Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.

Tirado I, Mateo J, Soria JM, Oliver A, Borrell M, Coll I, Vallvé C, Souto JC, Martínez-Sánchez E, Fontcuberta J.

Haematologica. 2001 Nov;86(11):1200-8.

15.

Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss.

Carp H, Salomon O, Seidman D, Dardik R, Rosenberg N, Inbal A.

Hum Reprod. 2002 Jun;17(6):1633-7.

16.

Thrombophilia in young patients with acute myocardial infarction.

Celik M, Altintas A, Celik Y, Karabulut A, Ayyildiz O.

Saudi Med J. 2008 Jan;29(1):48-54.

PMID:
18176672
17.

Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?

Gokalp D, Tuzcu A, Bahceci M, Ayyildiz O, Yurt M, Celik Y, Alpagat G.

Pituitary. 2011 Jun;14(2):168-73. doi: 10.1007/s11102-010-0276-x.

PMID:
21107737
18.
19.

Thrombophilia testing in patients with venous thrombosis.

Caprini JA, Goldshteyn S, Glase CJ, Hathaway K.

Eur J Vasc Endovasc Surg. 2005 Nov;30(5):550-5. Epub 2005 Aug 1.

20.

Legg-perthes disease and heritable thrombophilia.

López-Franco M, González-Morán G, De Lucas JC Jr, Llamas P, de Velasco JF, Vivancos JC, Epeldegui-Torre T.

J Pediatr Orthop. 2005 Jul-Aug;25(4):456-9.

PMID:
15958894
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk